About Jeff Skiba
Skiba started Vomaris Innovations, Inc. as a limited partnership eventually capitalized the company bringing in multiple investors and serving as CEO for 9 years.  Skiba has more than 28 years experience in leading medical device development and commercialization of first-to-market concepts. Skiba is the inventor of the Procellera® Wound Dressing with Microcurrent Technology for tissue regeneration.
Between 1998 and 2004 Skiba was Director of Manufacturing and Engineering at TriVascular, where he was involved in the development of a percutaneously delivered abdominal aortic aneurism repair endograft regulated as a PMA Medical device.  Skiba also founded JBS BioEngineering in 1999, where he served as President. Heading the design and development of surgical implants sector until 2004, he was responsible for the development of a urologic implant system for type 3 stress incontinence funded by a grant from the Office of Chief Scientist in Israel and co-developed with an Israeli medical device firm.
The device was granted FDA clearance and two patents. In addition, he developed a unique system for Eye Medication delivery. From 1993-1998, Skiba was Vice-President of Manufacturing and Engineering at Orthopaedic BioSystems Inc., where he directed the formation of the Research and Development Department, Inventory Management, Regulatory Submissions and a world class quality system approved by ISO and products stamped with the CE Mark for orthopaedic deep tissue implants and instrumentation. This company was eventually acquired by Smith + Nephew.
Skiba was a founder and Manager of Technical Services at International Polymer Engineering in 1992. There, he was responsible for the research and development of expanded PTFE polymers and PTFE production methods. Skiba is named on over 25 issued patents, many pending and has multiple peer reviewed publications.